SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Debt | ₹258 Cr | ₹47 Cr | ₹0.05 Cr |
What is the latest Total Debt ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹258 Cr |
| Mar2024 | ₹47 Cr |
| Mar2023 | ₹0.05 Cr |
How is Total Debt of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹258 Cr | 449.33 | |
| Mar2024 | ₹47 Cr | 92,056.86 | |
| Mar2023 | ₹0.05 Cr | - | |
Compare Total Debt of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹5,855.6 Cr | 10.3% | 25.3% | 13.7% | Stock Analytics | |
| PRIME FOCUS | ₹19,609.3 Cr | 1.9% | -22.9% | 160.3% | Stock Analytics | |
| SAGILITY | ₹19,404.1 Cr | -1.3% | -1.9% | -10% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹18,982.5 Cr | 3.5% | 6% | -27.7% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹16,223.3 Cr | 14.9% | 3.8% | -7% | Stock Analytics | |
| INDEGENE | ₹12,253.5 Cr | -1.4% | 4.3% | -16% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 10.3% |
25.3% |
13.7% |
| SENSEX | -0.3% |
-4.3% |
-8.9% |
You may also like the below Video Courses